Measures of maternal tobacco exposure and infant birth weight at term.

This study was undertaken to determine the relation between self-reported number of cigarettes smoked per day and urine cotinine concentration during pregnancy and to examine the relations between these two measures of tobacco exposure and birth weight. Data were obtained from the Smoking Cessation in Pregnancy project, conducted between 1987 and 1991. Cigarette smoking information and urine cotinine concentration were collected for 3,395 self-reported smokers who were receiving prenatal care at public clinics in three US states (Colorado, Maryland, and Missouri) and who delivered term infants. General linear models were used to quantify urine cotinine variability explained by the number of cigarettes smoked per day and to generate mean adjusted birth weights for women with different levels of tobacco exposure. Self-reported number of cigarettes smoked per day explained only 13.9% of the variability in urine cotinine concentration. Birth weight declined as tobacco exposure increased; however, the relation was not linear. The sharpest declines in birth weight occurred at low levels of exposure. Furthermore, urine cotinine concentration did not explain more variability in birth weight than did number of cigarettes smoked. These findings should be considered by researchers studying the effects of smoking reduction on birth outcomes.

[1]  P. Vacek,et al.  Estimated gains in birth weight associated with reductions in smoking during pregnancy. , 1998, The Journal of reproductive medicine.

[2]  C Osmond,et al.  Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.

[3]  J. Idle.  Titrating exposure to tobacco smoke using cotinine--a minefield of misunderstandings. , 1990, Journal of clinical epidemiology.

[4]  G. Giovino,et al.  Racial and Ethnic Differences in Serum Cotinine Levels of Cigarette Smokers , 1998 .

[5]  M. Mathai,et al.  Maternal Smoking, Urinary Cotinine Levels and Birth‐Weight , 1990, The Australian & New Zealand journal of obstetrics & gynaecology.

[6]  N. Benowitz,et al.  Daily intake of nicotine during cigarette smoking , 1984, Clinical pharmacology and therapeutics.

[7]  N. Benowitz,et al.  Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  R. Dersimonian,et al.  Serum cotinine concentration and self-reported smoking during pregnancy. , 1998, American journal of epidemiology.

[9]  Hiroshi Yamamoto,et al.  Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans , 2000, Clinical pharmacology and therapeutics.

[10]  E. Lieberman,et al.  Low birthweight at term and the timing of fetal exposure to maternal smoking. , 1994, American journal of public health.

[11]  G Gennser,et al.  A Study of Smoking and Pregnancy with Special Reference to Fetal Growth , 1978, Acta obstetricia et gynecologica Scandinavica. Supplement.

[12]  G. Giovino,et al.  Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. , 1998, JAMA.

[13]  S. Thompson,et al.  How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? , 1990, Clinica chimica acta; international journal of clinical chemistry.

[14]  B. Eskenazi,et al.  Black-white differences in serum cotinine levels among pregnant women and subsequent effects on infant birthweight. , 1994, American journal of public health.

[15]  C. Feyerabend,et al.  Nicotine concentrations in urine and saliva of smokers and non-smokers. , 1982, British medical journal.

[16]  G. Ellard,et al.  Smoking during pregnancy: the dose dependence of birthweight deficits , 1996, British journal of obstetrics and gynaecology.

[17]  J. Hebel,et al.  Dose-response of birth weight to various measures of maternal smoking during pregnancy. , 1988, Journal of clinical epidemiology.

[18]  C. MacArthur,et al.  Smoking in pregnancy: effects of stopping at different stages , 1988, British journal of obstetrics and gynaecology.

[19]  J. Kendrick,et al.  Integrating smoking cessation into routine public prenatal care: the Smoking Cessation in Pregnancy project. , 1995, American journal of public health.

[20]  F. Speizer,et al.  Maternal smoking during pregnancy, urine cotinine concentrations, and birth outcomes. A prospective cohort study. , 1997, International journal of epidemiology.

[21]  J Pikkarainen,et al.  Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking , 1993, British journal of obstetrics and gynaecology.

[22]  D. Barker.  Fetal origins of coronary heart disease , 1995, BMJ.

[23]  E. Abel.  Smoking during pregnancy: a review of effects on growth and development of offspring. , 1980, Human biology.

[24]  H. Meredith.  Relation between tobacco smoking of pregnant women and body size of their progeny: a compilation and synthesis of published studies. , 1975, Human biology.

[25]  N. Wald,et al.  Cigarette consumption and serum cotinine in relation to birthweight , 1987, British journal of obstetrics and gynaecology.

[26]  N. Benowitz,et al.  Recent studies of nicotine metabolism in humans , 1988, Pharmacology Biochemistry and Behavior.

[27]  R. Windsor,et al.  The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. , 1993, JAMA.

[28]  S Cnattingius,et al.  Cigarette smoking as a risk factor for sudden infant death syndrome: a population-based study. , 1990, American journal of public health.